Evolent Health (EVH) Stock Analysis & Winston Score
Evolent Health helps health insurance plans and hospital systems manage patients with complex, expensive medical conditions. The company focuses on specialty care areas like cancer treatment, heart disease, and musculoskeletal conditions, working with health plans as its main customers. It sits in the healthcare technology and services industry, acting as an outsourced partner that helps payers control costs and coordinate care for their sickest members. Evolent makes money by charging health plans fees tied to the number of members it manages, often taking on some financial risk for the cost of that care. The company operates primarily in the United States and has grown largely through acquisitions, including its purchase of specialty care management firm NIA. Its competitive position depends on deep clinical data and established health plan relationships, but the business currently runs at a thin operating loss, and its main risk is that taking on medical cost risk can hurt results sharply if patient care expenses come in higher than expected.
Winston Score: 11/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Weak (1/20)
- Cash Flow: Weak (1/10)
- Stability: Weak (1/10)
- Valuation: Data not available (0/10)
- Ownership: Mixed (6/15)
Key Facts
Price: $5.81
Market Cap: $654M
Sector: Healthcare
Industry: Medical - Healthcare Information Services

